BCSFBain Capital Specialty Finance, Inc.(BCSF)Stock Analysis

AI analysis on 2,800+ stocks →
NYSE
Institutional-grade research for retail investors
SEC EDGAR: CIK 1655050BCSF stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

BCSF Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Bain Capital Specialty Finance, Inc. (BCSF). BCSF is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q1 2026), Bain Capital Specialty Finance, Inc. reports net income of $3.4M, free cash flow of $26.6M. Top institutional holders of BCSF by reported 13-F value include Bain Capital Credit,, BANK OF AMERICA /DE/, Cresset Asset Management,, based on the most recent SEC filings. BCSF trades on the NYSE exchange and files with the SEC under CIK 1655050. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BCSF daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Bain Capital Specialty Finance, Inc. directly from SEC EDGAR.

Net Income

Q1 2026

$3.4M

Free Cash Flow

Q1 2026

$26.6M

D/E Ratio

Q1 2026

1.33

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Net Income

+3.0% YoY
$123.4MFY 2023
FY19 FY20 $8.3MFY21 $119.8MFY23 $123.4M

EPS (Diluted)

+2.7% YoY
$1.91FY 2023
FY19 FY20 $0.14FY21 $1.86FY23 $1.91

Total Assets

-3.8% YoY
$2.47BFY 2023
FY19 FY20 FY21 $2.57BFY23 $2.47B

Total Debt

-11.2% YoY
$1.26BFY 2023
FY19 FY20 FY21 $1.41BFY23 $1.26B

Op. Cash Flow

-17.4% YoY
$219.3MFY 2023
FY19 FY20 $89.4MFY21 $265.6MFY23 $219.3M

AI Insight: BCSF Financial Trends

Net income collapsed to $3M in Q1 2026 — lowest in the observed period — while equity erodes steadily and leverage remains elevated near $1.5B.

Net income dropped sharply to $3M in Q1 2026, down from $28M in Q4 2025 and well below the $29M–$33M range seen in mid-2024.

Total debt rose from $1,174M in Q2 2024 to a peak of $1,563M in Q2 2025, remaining elevated at $1,455M in Q1 2026.

Equity has declined every quarter from $1,143M in Q2 2024 to $1,094M in Q1 2026, a cumulative erosion of $49M.

Operating cash flow turned positive and stabilized, improving from $-136M in Q3 2024 to $27M in both Q4 2025 and Q1 2026.

Q1 2026 net income of $3M is a potential inflection — monitor whether this reflects one-time markdowns or a structural deterioration in portfolio yield.

Debt-to-equity ratio has risen as equity shrinks and debt stays near $1.5B; further equity erosion could pressure regulatory leverage limits.

Operating cash flow recovery to $27M is encouraging, but sustainability depends on whether net income rebounds from Q1 2026 lows.

AI Insight: BCSF Ratio Trends

ROE collapsed to 1.2% in Q1 2026 — the lowest single-quarter reading in the dataset — signaling a sharp, potentially one-off earnings disruption.

ROE plunged from 10.0% in Q4 2025 to 1.2% in Q1 2026, the weakest quarterly print across all observed periods.

ROA similarly fell from 4.2% in Q4 2025 to 0.5% in Q1 2026, the lowest in the dataset.

D/E has trended upward from 1.03 in Q2 2024 to 1.33 in Q1 2026, reflecting gradually rising leverage over the period.

Q1 2026 ROE of 1.2% vs. TTM ROE of 6.7% — confirm whether Q1 weakness is a one-off credit event or structural deterioration.

D/E at 1.33 is near its cycle high; further leverage expansion would compress equity returns and increase credit risk.

Get alerted when BCSF's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Bain Capital Specialty Finance, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of BCSF

Put BCSF on your watchlist

Track score changes the day Bain Capital Specialty Finance, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is BCSF a good stock to buy?

13F Pro's AI-powered analysis of Bain Capital Specialty Finance, Inc. (BCSF) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BCSF are available on the BCSF stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own BCSF?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BCSF. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Bain Capital Specialty Finance, Inc.'s investment landscape.